Clínica Baviera, S.A. (LON:0GWJ)
40.70
-0.20 (-0.49%)
At close: Nov 7, 2025
Clínica Baviera Revenue
Clínica Baviera had revenue of 74.52M EUR in the quarter ending June 30, 2025, with 11.96% growth. This brings the company's revenue in the last twelve months to 288.92M, up 18.75% year-over-year. In the year 2024, Clínica Baviera had annual revenue of 265.72M with 17.02% growth.
Revenue (ttm)
288.92M EUR
Revenue Growth
+18.75%
P/S Ratio
2.36
Revenue / Employee
164.25K EUR
Employees
1,759
Market Cap
584.11M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 265.72M | 38.66M | 17.02% |
| Dec 31, 2023 | 227.07M | 28.62M | 14.42% |
| Dec 31, 2022 | 198.45M | 25.20M | 14.55% |
| Dec 31, 2021 | 173.25M | 50.62M | 41.28% |
| Dec 31, 2020 | 122.63M | -1.71M | -1.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |